{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:35:12Z","timestamp":1781951712890,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-025-01661-5","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:23:50Z","timestamp":1761744230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["QbD-driven RP-HPLC method for the simultaneous analysis of dihydropyridines calcium channel blockers in pharmaceuticals"],"prefix":"10.1186","volume":"19","author":[{"given":"Mariana","family":"Horyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Piponski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liubomyr","family":"Kryskiw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdouh R.","family":"Rezk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadiya","family":"Zarivna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmytro","family":"Korobko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliya","family":"Logoyda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"1661_CR1","unstructured":"Hypertension \u2013 World Health Organization. https:\/\/www.who.int\/healthtopics\/hypertension#tab. Accessed 31 May 2024."},{"key":"1661_CR2","unstructured":"A Global Brief on Hypertension - World Health Organization. http:\/\/apps.who.int\/iris\/bitstream\/10665\/79059\/1\/WHO_DCO_WHD_2013.2_eng.pdf. Accessed 31 May 2024."},{"issue":"10","key":"1661_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41440-022-00997-y","volume":"45","author":"K Kario","year":"2022","unstructured":"Kario K, Hoshide S, Mogi M. Digital hypertension 2023: concept, hypothesis, and new technology. Hypertens Res. 2022;45(10):529\u201330.","journal-title":"Hypertens Res"},{"issue":"3","key":"1661_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tcm.2019.05.003","volume":"30","author":"JM Flack","year":"2020","unstructured":"Flack JM, Adekola B. Blood pressure and the new ACC\/AHA hypertension guidelines. Trends Cardiovasc Med. 2020;30(3):160\u20134.","journal-title":"Trends Cardiovasc Med"},{"issue":"38","key":"1661_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.15587\/2519-4852.2022.263733","volume":"4","author":"A Gonchar","year":"2022","unstructured":"Gonchar A, Sholoiko N. Consumption analysis of two-component fixed combinations of medicines for arterial hypertension treatment in Ukraine as one of the stages for evaluation of their reimbursement prospects. ScienceRise: Pharm Sci. 2022;4(38):19\u201327.","journal-title":"ScienceRise: Pharm Sci"},{"key":"1661_CR6","unstructured":"DailyMed \u2013 National Library of Medicine. https:\/\/dailymed.nlm.nih.gov\/dailymed\/browse-drug-classes.cfm. Accessed 31 May 2024."},{"key":"1661_CR7","unstructured":"European Pharmacopoeia. European Pharmacopoeia. 11 ed. 2022. https:\/\/www.edqm.eu\/en\/european-pharmacopoeia-ph.-eur.-11th-edition. Accessed 22 Mar 2023."},{"key":"1661_CR8","unstructured":"The United States Pharmacopeia. The National Formulary. Rockville, Md.: United States Pharmacopeial Convention, Inc. 2021. https:\/\/www.uspnf.com. Accessed 22 Mar 2023."},{"issue":"9","key":"1661_CR9","doi-asserted-by":"publisher","first-page":"e19993","DOI":"10.1016\/j.heliyon.2023.e19993","volume":"9","author":"S Jeelani","year":"2023","unstructured":"Jeelani S, Kouznetsova N. A new stability-indicating HPLC-UV method for determination of amlodipine besylate and its impurities in drug substance. Heliyon. 2023; 9(9):e19993.","journal-title":"Heliyon"},{"issue":"1","key":"1661_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/chromsci\/bms200","volume":"52","author":"M Sharma","year":"2014","unstructured":"Sharma M, Kothari C, Sherikar O, Mehta P. Concurrent estimation of amlodipine besylate, hydrochlorothiazide and valsartan by RP-HPLC, HPTLC and UV\u2013spectrophotometry. J Chromatogr Sci. 2014;52(1):27\u201335.","journal-title":"J Chromatogr Sci"},{"key":"1661_CR11","doi-asserted-by":"publisher","first-page":"S3021","DOI":"10.1016\/j.arabjc.2013.11.043","volume":"10","author":"A Kavathia","year":"2017","unstructured":"Kavathia A, Misra M. Development and validation of RP-HPLC and UV-spectrophotometric methods for rapid simultaneous estimation of amlodipine and benazepril in pure and fixed dose combination. Arab J Chem. 2017; 10:S3021\u2013S3028.","journal-title":"Arab J Chem"},{"issue":"2","key":"1661_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/jaoac\/89.2.359","volume":"89","author":"MD Malesuik","year":"2006","unstructured":"Malesuik MD, Cardoso SG, Bajerski L, Lanzanova FA. Determination of amlodipine in pharmaceutical dosage forms by liquid chromatography and ultraviolet spectrophotometry. J AOAC Int. 2006;89(2):359\u201364.","journal-title":"J AOAC Int"},{"issue":"1","key":"1661_CR13","first-page":"74","volume":"5","author":"S Maimoon","year":"2017","unstructured":"Maimoon S, Reddy KNK, Swetha P. RP-HPLC method development and validation for simultaneous Estimation of amlodipine besylate and Telmisartan in tablet dosage form. Indian J Res Pharm Biotechnol. 2017;5(1):74.","journal-title":"Indian J Res Pharm Biotechnol"},{"issue":"2","key":"1661_CR14","first-page":"200","volume":"8","author":"Meshwa","year":"2017","unstructured":"Meshwa, et al. Development and validation of HPLC method for Estimation of nimodipine in soft gelatin capsule. Pharma Sci Monit. 2017;8(2):200\u20139.","journal-title":"Pharma Sci Monit"},{"issue":"3","key":"1661_CR15","first-page":"370","volume":"27","author":"Praveenraj","year":"2024","unstructured":"Praveenraj, Kumar. Development and validation of stability-indicating RP-HPLC method for the simultaneous determination of citicoline and nimodipine in bulk and tablets. Afr J Biomed Res. 2024;27(3):370\u20136.","journal-title":"Afr J Biomed Res"},{"issue":"1","key":"1661_CR16","doi-asserted-by":"publisher","first-page":"612082","DOI":"10.1155\/2013\/612082","volume":"2013","author":"X Shang","year":"2013","unstructured":"Shang X, Ma S, Li Z. Development and validation of a RP-HPLC method for determination of nimodipine in sustained release tablets. J Chem. 2013;2013(1):612082.","journal-title":"J Chem"},{"issue":"23","key":"1661_CR17","first-page":"1306","volume":"13","author":"SP Girase","year":"2024","unstructured":"Girase SP, Chetna R, Mahajan, Pratibha S. Mali. Development and validation of stability indicating HPLC method for Estimation of Nifedipine in extended-release tablet dosage form. World J Pharm Res. 2024;13(23):1306\u201316.","journal-title":"World J Pharm Res"},{"issue":"8","key":"1661_CR18","doi-asserted-by":"publisher","first-page":"017","DOI":"10.7324\/JAPS.2015.50804","volume":"5","author":"H Hashem","year":"2015","unstructured":"Hashem H, Ehab IA, Magda E. A novel stability indicating HPLC-method for simultaneous determination of Atenolol and Nifedipine in presence of Atenolol pharmacopeoial impurities. J Appl Pharm Sci. 2015;5(8):017\u201325.","journal-title":"J Appl Pharm Sci"},{"issue":"2","key":"1661_CR19","first-page":"368","volume":"31","author":"Zhang","year":"2011","unstructured":"Zhang, Min-juan, et al. RP-HPLC determination of Nifedipine tablets. Chin J Pharm Anal. 2011;31(2):368\u201370.","journal-title":"Chin J Pharm Anal"},{"issue":"8","key":"1661_CR20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/chromsci\/bmab088","volume":"59","author":"AA El-Masry","year":"2021","unstructured":"El-Masry AA, El-Wasseef DR, Eid M, Shehata IA, Zeid AM. Optimization and validation of a facile RP-HPLC method for determination of Betrixaban and lercanidipine in pharmaceutical and biological matrices. J Chromatogr Sci. 2021;59(8):785\u201394.","journal-title":"J Chromatogr Sci"},{"issue":"1","key":"1661_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/0976-0105.170586","volume":"7","author":"N Udupa","year":"2016","unstructured":"Udupa N, Chonkar A, Managuli R, Rao J. Development and validation of reversed phase high-performance liquid chromatography method for Estimation of lercanidipine HCl in pure form and from nanosuspension formulation. J Basic Clin Pharm. 2016;7(1):17\u201322.","journal-title":"J Basic Clin Pharm"},{"issue":"12","key":"1661_CR22","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.14233\/ajchem.2017.20905","volume":"29","author":"C Bonde","year":"2017","unstructured":"Bonde C, Bonde S, Gawad JK. Application of quality by design for development and validation of RP-HPLC method for lercanidipine hydrochloride. Asian J Chem. 2017;29(12):2785\u201393.","journal-title":"Asian J Chem"},{"key":"1661_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/10826076.2010.534411","volume":"34","author":"DR El-Wasseef","year":"2010","unstructured":"El-Wasseef DR, El-Sherbiny DT, Abu El-Enin MA, El-Ashry SM. Simultaneous in vitro HPLC determination of Enalapril maleate and lercanidipine HCl. J Liq Chromatogr Relat Technol. 2010;34:48\u201360.","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"1661_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3797\/scipharm.1310-10","volume":"82","author":"S Mehta","year":"2014","unstructured":"Mehta S, Singh S, Chikhalia K. A fast, stability-indicating, and validated liquid chromatography method for the purity control of lercanidipine hydrochloride in tablet dosage form. Sci Pharm. 2014;82:327\u201340.","journal-title":"Sci Pharm"},{"key":"1661_CR25","first-page":"17","volume":"7","author":"AD Chonkar","year":"2015","unstructured":"Chonkar AD, Managuli RS, Rao JV, Udupa N. Development and validation of reversed phase high-performance liquid chromatography method for Estimation of lercanidipine HCl in pure form and from nanosuspension formulation. J Basic Clin Pharm. 2015;7:17\u201322.","journal-title":"J Basic Clin Pharm"},{"key":"1661_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4103\/0250-474X.70490","volume":"72","author":"HO Kaila","year":"2010","unstructured":"Kaila HO, Ambasana MA, Thakkar RS, Saravaia HT, Shah AK. A stability-indicating HPLC method for assay of lercanidipine hydrochloride in tablets and for determining content uniformity. Indian J Pharm Sci. 2010;72:381\u20134.","journal-title":"Indian J Pharm Sci"},{"key":"1661_CR27","first-page":"376","volume":"73","author":"HO Kaila","year":"2011","unstructured":"Kaila HO, Ambasana MA, Thakkar RS, Saravaia HT, Shah AK. A stability-indicating high performance liquid chromatographic assay for the simultaneous determination of Atenolol and lercanidipine hydrochloride in tablets. Indian J Pharm Sci. 2011;73:376\u201380.","journal-title":"Indian J Pharm Sci"},{"key":"1661_CR28","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s10337-013-2465-z","volume":"76","author":"S Kurbanoglu","year":"2013","unstructured":"Kurbanoglu S, Gumustas M, Uslu B, Ozkan SA. A sensitive and selective RP-LC method for the simultaneous determination of the antihypertensive drugs, enalapril, lercanidipine, nitrendipine and their validation. Chromatographia. 2013;76:1477\u201385.","journal-title":"Chromatographia"},{"issue":"4","key":"1661_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.22159\/ijap.2022v14i4.44531","volume":"14","author":"T Alumuri","year":"2022","unstructured":"Alumuri T, Amarababu NLA, Kurnool A, Kanuparthy PR, Merugu K. Development and validation of a stability indicating related substances of Atenolol and nitrendipine by RP-HPLC. Int J Appl Pharm. 2022;14(4):265\u201373.","journal-title":"Int J Appl Pharm"},{"key":"1661_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.9734\/bpi\/cops\/v3\/3623C","volume":"3","author":"K Merugu","year":"2023","unstructured":"Merugu K, Alumuri T, Kurnool A. Development and validation of a stability indicating related substances of Atenolol and nitrendipine by RP-HPLC. Curr Overv Pharm Sci. 2023;3:52\u201374.","journal-title":"Curr Overv Pharm Sci"},{"issue":"3","key":"1661_CR31","first-page":"574","volume":"31","author":"YR Ma","year":"2011","unstructured":"Ma YR, Sun T, Guo YS. HPLC determination of nitrendipine tablets. Chin J Pharm Anal. 2011;31(3):574\u20135.","journal-title":"Chin J Pharm Anal"},{"key":"1661_CR32","unstructured":"PubChem\u2014National Library of Medicine. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/. Accessed 31 May 2024."},{"key":"1661_CR33","unstructured":"ICH I. Q9 (R1) Quality risk management. In: International conference on harmonization of technical requirements for registration of Pharmaceuticals for Human use considerations; 2023. https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q9%28R1%29_Guideline_Step4_2022_1219.pdf"},{"key":"1661_CR34","unstructured":"ICH Q2 (R2) Validation of analytical procedures\u2014scientific guideline. Geneva; 2023. https:\/\/www.ema.europa.eu\/en\/ich-q2r2-validation-analytical-procedures-scientific-guideline. Accessed 24 June 2024."},{"key":"1661_CR35","doi-asserted-by":"crossref","unstructured":"Boobalan P, Gorantlaa SR, Pandurangan G, Swathikrishna V, Kavulurua PV. Journal of Comprehensive Pharmacy. Pena-Pereira F, Wojnowski W. & Tobiszewski M. AGREE\u2013Analytical GREEnness metric approach and software. Anal Chem. 2020; 92(14):10076\u201310082.","DOI":"10.1021\/acs.analchem.0c01887"},{"issue":"3","key":"1661_CR36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/analytica5030030","volume":"5","author":"FR Mansour","year":"2024","unstructured":"Mansour FR, P\u0142otka-Wasylka J, Locatelli M. Modified GAPI (MoGAPI) tool and software for the assessment of method greenness: case studies and applications. Analytica. 2024;5(3):451\u20137.","journal-title":"Analytica"},{"key":"1661_CR37","doi-asserted-by":"publisher","first-page":"100126","DOI":"10.1016\/j.greeac.2024.100126","volume":"10","author":"FR Mansour","year":"2024","unstructured":"Mansour FR, Omer KM, P\u0142otka-Wasylka J. A total scoring system and software for complex modified GAPI (ComplexMoGAPI) application in the assessment of method greenness. Green Anal Chem. 2024;10:100126.","journal-title":"Green Anal Chem"},{"key":"1661_CR38","doi-asserted-by":"publisher","first-page":"102051","DOI":"10.1016\/j.scp.2025.102051","volume":"46","author":"FR Mansour","year":"2025","unstructured":"Mansour FR, Bedair A, Belal F, Magdy G, Locatelli M. Analytical green star area (AGSA) as a new tool to assess greenness of analytical methods. Sustain Chem Pharm. 2025; 46:102051.","journal-title":"Sustain Chem Pharm"},{"key":"1661_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13065-025-01486-2","volume":"19","author":"FR Mansour","year":"2025","unstructured":"Mansour FR, Nowak PM. Introducing the carbon footprint reduction index (CaFRI) as a software-supported tool for greener laboratories in chemical analysis. BMC Chem. 2025;19:121.","journal-title":"BMC Chem"},{"issue":"19","key":"1661_CR40","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1039\/D3GC02347H","volume":"25","author":"N Manousi","year":"2023","unstructured":"Manousi N, Wojnowski W, P\u0142otka-Wasylka J, Samanidou V. Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality. Green Chem. 2023;25(19):7598\u2013604.","journal-title":"Green Chem"},{"key":"1661_CR41","doi-asserted-by":"publisher","first-page":"100164","DOI":"10.1016\/j.sampre.2025.100164","volume":"14","author":"FR Mansour","year":"2025","unstructured":"Mansour FR, Bedair A, Locatelli M. Click analytical chemistry index as a novel concept and framework, supported with open source software to assess analytical methods. Adv Sample Preparation. 2025;14:100164.","journal-title":"Adv Sample Preparation"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01661-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01661-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01661-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:23:57Z","timestamp":1761744237000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01661-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1661"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01661-5","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Guidelines according to BMC Chemistry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"289"}}